Dimensional Fund Advisors’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Dimensional Fund Advisors’s Portfolio ORGS Stock Details ORGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,654	Closed	-$23K	–	3515
2023 Q2	$23K	Sell	1,654 -2,017	-55%	-$23.9K	﹤0.01%	3447
2023 Q1	$43.3K	Buy	+3,671	New	+$68.9K	﹤0.01%	3394
2022 Q3	$35K	Sell	2,441 -541	-18%	-$10.2K	﹤0.01%	3437
2022 Q2	$72K	Buy	2,982 +605	+25%	+$16.8K	﹤0.01%	3365
2022 Q1	$82K	Sell	2,377 -20	-0.8%	-$608	﹤0.01%	3415
2021 Q4	$69K	Sell	2,397 -128	-5%	-$5.01K	﹤0.01%	3464
2021 Q3	$125K	Buy	2,525 +610	+32%	+$30.6K	﹤0.01%	3403
2021 Q2	$97K	Buy	1,915 +81	+4%	+$4.08K	﹤0.01%	3412
2021 Q1	$105K	Buy	1,834 +771	+73%	+$50.2K	﹤0.01%	3346
2020 Q4	$48K	Buy	1,063 +1	+0.1%	+$48	﹤0.01%	3318
2020 Q3	$54K	Buy	+1,062	New	+$57.6K	﹤0.01%	3304

Other funds holding ORGS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank Hapoalim BM Tel Aviv, Israel $1.5B AUM 26.39% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Dimensional Fund Advisors's ORGS Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2023, closing a stake of 1,654 shares — an estimated $23K sold.

Dimensional Fund Advisors first reported a position in ORGS in Q3 2020 and held it in 11 quarters. The position peaked at $125K in Q3 2021. 20 funds tracked by Wall St. Rank hold ORGS as of Q3 2023.

Dimensional Fund Advisors reported no remaining Orgenesis Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Dimensional Fund Advisors sold 1,654 Orgenesis Inc. Common Stock shares in Q3 2023, an estimated $23K.
Dimensional Fund Advisors first reported a position in Orgenesis Inc. Common Stock in Q3 2020 and held it in 11 quarters.
Dimensional Fund Advisors's Orgenesis Inc. Common Stock position peaked at $125K in Q3 2021.
20 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.